000			01426nam a2200133Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aRadiolabeled Compounds for Diagnosis and Treatment of Cancer
546			_aEnglish[eng]
650			_apositron emission tomography (PET)||pyrazoles||fluorine-18||radionuclides||PET probes||imaging pharmaceuticals||hypopharyngeal cancer||188Re-liposome||repeated therapy||NGS||microRNA||aprepitant||radiopharmaceuticals||neurokinin 1 receptor antagonist||radionuclide chelators||kidney uptake||cleavable linkers||neutral endopeptidase (NEP)||renal brush border enzymes||prostate-specific membrane antigen (PSMA)||cancer imaging and therapy||somatostatin analogs||radiolabeling||radionuclide therapy||imaging||adrenergic receptor||positron emission tomography||radiotracer||cholecystokinin-2 receptor||minigastrin||molecular imaging||targeted radiotherapy||lutetium-177||EpCAM||radionuclide||SPECT||iodine||PIB||breast||cancer||PET||target-specific biomolecules||immunoPET imaging pharmaceuticals||production processes||124I-labeled monoclonal antibodies||radiotracers||AAZTA||scandium-44||FAP||SA||DPP||PREP||radioiodine labeling||radioiodination||biomolecules||peptides||proteins||monoclonal antibodies||123,124,125,131I-labeled molecules and biomolecules||n/a
700			_aKumar, Krishan
856			_uhttps://mdpi.com/books/pdfview/book/4658
942			_cEB
999			_c19106 _d19106